期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

噁唑烷酮类抗菌剂的合成 被引量：10

Progress of Synthesis of Antibacterial Oxazolidinones
暂未订购
导出
摘要 综述了近年来合成唑烷酮类抗菌剂中的构成唑烷酮的环合反应和 5 The synthesis of antibacterial oxazolidinones was reviewed. The attention was paid to the cyclization of oxazolidinone ring and the modifications on 5 substituents.
作者 李荣坡 周伟澄
机构地区 上海医药工业研究院
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2003年第6期302-309,共8页 Chinese Journal of Pharmaceuticals
关键词 噁唑烷酮 合成 抗菌剂 综述 oxazolidinone synthesis antibacterial agents review
分类号 R978.19 [医药卫生—药品]
  • 相关文献

参考文献36

  • 1马翔,周伟澄.新型全合成抗菌药噁唑烷酮类化合物的研究进展[J].中国医药工业杂志,2000,31(8):370-376. 被引量：14
  • 2刘继东,周伟澄.抗肺结核药物研究进展[J].中国医药工业杂志,2002,33(3):147-151. 被引量：3
  • 3南京大学有机化学教研室.有机化学[M].北京：高等教育出版社,1979.176.
  • 4Tokuyama R, Takahashi Y, Tomita Y, et al. Structure-activity relationship(SAR) studies on oxazolidinone antibacterial agents. 1. Conversion of 5-substituent on oxazolidinone [J]. Chem Pharm Bull,2001,49(4) :347-352.
  • 5Gravestock MB. Antibacterial oxazolidinone derivatives[P]. WO: 99164416,1999-12-16. (CA 2000,132:35693z).
  • 6Gravestock MB. Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them as antibiotics [P]. WO:99164417,1999-12-16. (CA 2000, 132:35694a).
  • 7Barbachyn MR, Hutchinson DK, Brickner SJ,et al.Identification of a novel oxazolidinone (U-100480)with potent antimycobacterial activity [J]. J Med Chem, 1996,39(3) : 680-685.
  • 8Straub A, Lampe T, Pohlmann J, et al. Preparation of 5-acylaminomethyloxazolidin-2-ones as Factor Xa inhibitors[P]. DE : 19962924,1999-12-24. (CA 2001,135:92625q).
  • 9(a)Genin MJ, Barbachyn MR, Hester JB, et al.Preparation of bicyclyloxazolidinones as antibacterials [P]. WO: 2000073301, 2000-12-07. (CA 2001,134 : 29408k) .
  • 10Gregory WA, Brittelli DR, Wang CLJ, et al. Antibacterials. Synthesis and structure-activity studies of 3-aryl-2-oxazolidinones. 1. The "B" group[J]. J Med Chem, 1989,32(8) : 1673-1681.

二级参考文献32

  • 1[1]Parrish NM, Dick JD,Bishai WR. Mechanisms of latency in mycobacterium tuberculosis [J].Trends Microbiol, 1998,6:107-112.
  • 2[2]何广学.世界防治结核病的意义[N].中国医药报,2001-03-24(2).
  • 3[3]周欣.中国结核病的流行趋势[N].中国医药报,2001-03-25(1).
  • 4[4]Anon. TB still increasing despite DOTS [J]. Scrip, 2001,(2630):16.
  • 5[5]Jacobs MR. Activity of quinolones against mycobacteria [J]. Drugs, 1999,58(Suppl 2):19-22.
  • 6[6]Ruiz-Serrano MJ, Alcala L, Martinez L, et al. In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs [J]. Antimicrob Agents Chemother, 2000,44(9):2567-2568.
  • 7[7]Tomioka H, Sato K, Kajitani H, et al. Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155),and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex [J]. Antimicrob Agents Chemother, 1999,43:3001-3004.
  • 8[8]Tomioka H, Sato K, Kajitani H,et al. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034,levofloxacin, sparfloxacin and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex[J]. Antimicrob Agents Chemther, 2000,44:283-286.
  • 9[9]Satio H. Comparative antimycobacterial activity of BAY-12-8039 and gatifloxacin [J]. Drugs, 1999,58(Suppl 2): 401.
  • 10[10]Ji BH, Lounis N, Maslo c, et al. In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis [J].Antimicrob Agents Chemother, 1998,42:2066-2069.

共引文献15

同被引文献91

引证文献10

二级引证文献23

中国医药工业杂志
2003年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部